Overview

The Risk Assessment and Prevention Program (RAPP) at Invision Sally Jobe provides patients with a personalized assessment of their breast cancer risk, as well as individualized recommendations for cancer screening and prevention. Each and every patient who comes to Invision Sally Jobe for any type of breast imaging exam receives this initial assessment. After the exam, any relevant recommendations are communicated to their referring doctor(s) as part of the imaging report, as well as to the patient directly via a separate letter. Patients who have already had breast cancer are evaluated as well to determine whether their cancer might have been caused by a hereditary breast cancer syndrome.

The RAPP program is overseen by a board-certified cancer genetic counselor that is available for consultation with patients, either in person or via telephone. Learn more about these consultations.

For More Information

For more information, please view our Frequently Asked Questions page.

Patients with additional questions can call our genetic counselor at 720-493-3229 or send an email to rapp@riaco.com. To schedule a visit with our genetic counselor, please contact Centralized Scheduling at 720-493-3700.






Options for Women at High Risk

Various options are available for women who are at elevated risk for breast cancer, such as supplemental breast cancer screening, genetic counseling/testing, and chemoprevention.

Learn more about these high risk options.

Determining Cancer Risk

What is my risk?

The average woman has a 12% (1 in 8) chance to develop breast cancer in her lifetime. Some women have a higher-than-average risk for breast cancer. This may be due to a variety of factors, such as family history, breast density, and hormonal factors. Various computer-based models are available to assess breast cancer risk and, depending on a woman’s individual level of risk, different medical management options may be available for consideration by her and her doctor(s).

Risk Assessment Models

The models used in our Risk Assessment and Prevention Program are endorsed by the American Cancer Society and include: